About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Oncology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
J
Treatment Options in R/R Multiple Myeloma: Tips for Selecting Among the Myriad Of Choices
By
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
FEATURING
Jesus Berdeja
March 13, 2020
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
14:16
2nd SOHO Italian Conference
2020 SOHO Update on MM: What Is the Role of Transplant and MRD? How Do Tri…
Feat.
K. Anderson
05:11
UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts
ASH Updates on R/R MM: How to Choose Amongst Available Regimens at 1st Rel…
Feat.
B. Derman
05:09
Association of Community Cancer Centers (ACCC)
72 y/o Woman With IgG Lambda High-Risk Multiple Myeloma (del17p): Disease …
Feat.
K. Maples
18:43
7th Eurasian Hematology Oncology Summit
2020 Updates on CAR-T in R/R MM: What Is the Incidence of AEs With bb2121?…
Feat.
E. Terpos
30:19
SOHO Italy 1st School of Multiple Myeloma
Present & Near Future of R/R MM: Post-Bortezomib, Post-Lenalidomide, Selin…
Feat.
C. Cerchione
23:44
UAB Hematology Review 2021
Updates on R/R MM: Is PFS Improved With KdD vs. Kd, IKd vs. Kd, Isa-Pd vs.…
Feat.
K. Godby
12:53
2nd SOHO Italian Conference
Genetic Profiling in MM: Can Genomics Help With High-Risk Disease? How Can…
Feat.
N. Bolli
14:15
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
MRD in Multiple Myeloma Isn't Ready for Prime Time: More Patients Can Achi…
Feat.
T. Martin
26:18
Morie Gertz
Treatment of Relapsed Myeloma: Overview of Approved Drugs & Optimal Sequen…
08:15
2018 Pan Pacific Lymphoma Conference
Evolution of Myeloma Induction Regimens
Feat.
S. Holstein
25:51
KU ASH 2018 Review: Current Updates in Hematologic Diseases
MM - Overview of Trials Presented at ASH 2018
Feat.
A. Abdallah
12:16
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Discrepancy Between Real World vs. Clinical Trial Data in Relapsed/Refract…
Feat.
M. Dimopoulos
12:03
Andrew Cowan
BCMA CAR-T + Gamma Secretase Inhibitor Appear to Be Well Tolerated in R/R …
15:22
SOHO Italy 1st School of Multiple Myeloma
Dissecting Daratumumab Mechanisms of Resistance in MM: Identification of N…
Feat.
M. Claudio Da Via
09:50
Nina Shah
Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Mainten…
06:12
Indy Hematology Review
Targeting Mutations in Myeloma with Venetoclax and Development of the Fi...
Feat.
K. Anderson
19:41
Peter Voorhees
Approach to the Patient with Refractory & Multiple Relapsed Multiple Myelo…
10:30
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Next Questions in Myeloma: Biology, Smoldering Myeloma, High-risk, MRD, an…
Feat.
S. Jagannath
15:02
Krina Patel
Clinical Trials in Myeloma in 2018
15:47
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Mana…
Feat.
S. Lonial